Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
March 10, 2009
0Patent Application Number
112291620
Date Filed
September 16, 2005
0Patent Citations Received
...
Patent Primary Examiner
Patent abstract
This invention relates to anti-OX40L antibodies and, in particular, to anti-OX40L antibodies and variants thereof that contain a Fc part derived from human origin and do not bind complement factor C1q. These antibodies have new and inventive properties causing a benefit for a patient suffering from inflammatory diseases.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.